• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝酸盐与心绞痛

Nitrates and angina pectoris.

作者信息

Parker J O

机构信息

Kingston General Hospital, Ontario, Canada.

出版信息

Am J Cardiol. 1993 Sep 9;72(8):3C-6C; discussion 6C-8C. doi: 10.1016/0002-9149(93)90248-b.

DOI:10.1016/0002-9149(93)90248-b
PMID:8372799
Abstract

This review discusses the mechanisms of action of the organic nitrates, nitrate tolerance, and the effects of nitrates in patients with stable angina pectoris. The nitrates are prodrugs that enter the vascular smooth muscle, where they are denitrated to form the active agent nitric oxide (NO). NO activates guanylate cyclase, which results in cyclic guanosine monophosphate (cGMP) production and vasodilation as a result of reuptake of calcium by the sarcoplasmic reticulum. NO is identical to endothelium-derived relaxing factor (EDRF), which induces vasodilation, inhibits platelet aggregation, reduces endothelium adhesion, and has anticoagulant and fibrinolytic effects. Thus, the nitrates may be more than vasodilators and, in addition to reducing ischemia, may affect the process of atherosclerosis. The vascular effects of nitrates are attenuated during sustained therapy. Although the basis for the phenomenon of nitrate tolerance is not completely understood, sulfhydryl depletion as well as neurohormonal activation and increased plasma volume may be involved. The administration of N-acetylcysteine, angiotensin-converting enzyme (ACE) inhibitors, or diuretics do not consistently prevent nitrate tolerance. At present, intermittent nitrate therapy is the only way to avoid nitrate tolerance. The intermittent administration of nitrates, however, cannot provide continuous therapeutic benefits, and thus monotherapy with nitrates is not suitable for many patients with stable angina pectoris.

摘要

本综述讨论了有机硝酸盐的作用机制、硝酸盐耐受性以及硝酸盐对稳定型心绞痛患者的影响。硝酸盐是前体药物,进入血管平滑肌后被脱硝形成活性剂一氧化氮(NO)。NO激活鸟苷酸环化酶,导致环磷酸鸟苷(cGMP)生成,并因肌浆网对钙的再摄取而引起血管舒张。NO与内皮源性舒张因子(EDRF)相同,可诱导血管舒张、抑制血小板聚集、减少内皮黏附,并具有抗凝和纤溶作用。因此,硝酸盐可能不仅仅是血管扩张剂,除了减轻缺血外,还可能影响动脉粥样硬化进程。在持续治疗期间,硝酸盐的血管效应会减弱。尽管硝酸盐耐受性现象的基础尚未完全了解,但可能涉及巯基耗竭以及神经激素激活和血容量增加。给予N-乙酰半胱氨酸、血管紧张素转换酶(ACE)抑制剂或利尿剂并不能始终预防硝酸盐耐受性。目前,间歇使用硝酸盐疗法是避免硝酸盐耐受性的唯一方法。然而,间歇给予硝酸盐不能提供持续的治疗益处,因此硝酸盐单一疗法不适用于许多稳定型心绞痛患者。

相似文献

1
Nitrates and angina pectoris.硝酸盐与心绞痛
Am J Cardiol. 1993 Sep 9;72(8):3C-6C; discussion 6C-8C. doi: 10.1016/0002-9149(93)90248-b.
2
Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure.硝酸酯类药物耐受性、反跳现象及其在稳定型心绞痛、不稳定型心绞痛和心力衰竭中的临床意义
Cardiovasc Drugs Ther. 1997 Jan;10(6):735-42. doi: 10.1007/BF00053031.
3
Interactions between organic nitrates and thiol groups.有机硝酸盐与硫醇基团之间的相互作用。
Am J Med. 1991 Sep 30;91(3C):106S-112S. doi: 10.1016/0002-9343(91)90292-6.
4
Oral nitrates: more than symptomatic therapy in coronary artery disease?口服硝酸盐类药物:在冠状动脉疾病中不仅仅是对症治疗?
Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:213-8. doi: 10.1023/a:1007750706831.
5
Nitrate tolerance--can it be prevented?硝酸酯类药物耐受性——能否预防?
Eur Heart J. 1991 May;12 Suppl A:13-5.
6
[Characteristics of angina pectoris therapy with nitrates].[硝酸酯类药物治疗心绞痛的特点]
Herz. 1996 Jun;21 Suppl 1:4-22.
7
Efficacy of different forms of nitrates in angina pectoris.不同形式硝酸盐类药物治疗心绞痛的疗效
Acta Med Scand Suppl. 1985;694:153-65. doi: 10.1111/j.0954-6820.1985.tb08811.x.
8
Nitrate tolerance in angina therapy. How to avoid it.心绞痛治疗中的硝酸盐耐受性。如何避免它。
Drugs. 1995 Feb;49(2):196-9. doi: 10.2165/00003495-199549020-00004.
9
Nitrate tolerance--from mechanism to prevention.硝酸酯类药物耐受性——从机制到预防
Indian Heart J. 1997 Sep-Oct;49(5):487-8.
10
Nitrate therapy for stable angina pectoris.用于稳定型心绞痛的硝酸盐疗法。
N Engl J Med. 1998 Feb 19;338(8):520-31. doi: 10.1056/NEJM199802193380807.

引用本文的文献

1
A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection.基于疾病组群的可溶性鸟苷酸环化酶激活剂的药物再利用:从平滑肌舒张到直接神经保护
NPJ Syst Biol Appl. 2018 Feb 5;4:8. doi: 10.1038/s41540-017-0039-7. eCollection 2018.
2
Efficacy and Safety of Dorocontin(®) versus Sustac(®) in the Treatment of Stable Angina Pectoris: A Randomized, Double-Blind Comparative Trial.多罗康定(®)与舒他可(®)治疗稳定型心绞痛的疗效与安全性:一项随机双盲对照试验
Sci Pharm. 2014 Aug 16;82(4):815-24. doi: 10.3797/scipharm.1406-16. Print 2014 Oct-Dec.